SAN DIEGO--(BUSINESS WIRE)--Dec. 20, 2018-- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.
J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 7, 2019
Presentation at 3:00 pm Pacific Time followed by a Q&A Session at 3:30 pm Pacific Time
The live webcast can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com. A replay of the presentation will be posted on Illumina’s web site after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181220005549/en/
Source: Illumina, Inc.
Investors:
Jacquie Ross, CFA
858-882-2172
ir@illumina.com
Media:
Eric Endicott
858-882-6822
pr@illumina.com
